These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 11216539

  • 21. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 22. Biodistribution and internal dosimetry of the 188Re-labelled humanized monoclonal antibody anti-epidemal growth factor receptor, nimotuzumab, in the locoregional treatment of malignant gliomas.
    Torres LA, Coca MA, Batista JF, Casaco A, Lopez G, García I, Perera A, Peña Y, Hernández A, Sanchez Y, Romero S, Leyva R, Prats A, Fernandez R.
    Nucl Med Commun; 2008 Jan; 29(1):66-75. PubMed ID: 18049099
    [Abstract] [Full Text] [Related]

  • 23. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.
    Wallhaus TR, Lacy J, Whang J, Green MA, Nickles RJ, Stone CK.
    J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Dynamic distribution and dosimetric evaluation of human non-specific immunoglobulin G labelled with 111In or 99Tcm.
    Buijs WC, Oyen WJ, Dams ET, Boerman OC, Siegel JA, Claessens RA, van der Meer JW, Corstens FH.
    Nucl Med Commun; 1998 Aug; 19(8):743-51. PubMed ID: 9751928
    [Abstract] [Full Text] [Related]

  • 26. [44Sc]Sc-PSMA-617 Biodistribution and Dosimetry in Patients With Metastatic Castration-Resistant Prostate Carcinoma.
    Khawar A, Eppard E, Sinnes JP, Roesch F, Ahmadzadehfar H, Kürpig S, Meisenheimer M, Gaertner FC, Essler M, Bundschuh RA.
    Clin Nucl Med; 2018 May; 43(5):323-330. PubMed ID: 29485430
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Biodistribution and dosimetry of indium-111-polyclonal IgG in normal subjects.
    Datz FL, Castronovo FP, Christian PE, Anderson CE, Crebs K, Morton KA, Rauh DA.
    J Nucl Med; 1995 Dec; 36(12):2372-9. PubMed ID: 8523134
    [Abstract] [Full Text] [Related]

  • 29. 99mTc-HMPAO as a tracer of cerebral blood flow in newborn infants.
    Børch K, Greisen G.
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):448-54. PubMed ID: 9143227
    [Abstract] [Full Text] [Related]

  • 30. Absorbed radiation dose to humans from technetium-99m-teboroxime.
    Narra RK, Feld T, Nunn AD.
    J Nucl Med; 1992 Jan; 33(1):88-93. PubMed ID: 1731003
    [Abstract] [Full Text] [Related]

  • 31. The effect of vincristine on the biodistribution of technetium-99m DTPA, GHA, and DMSA in Balb/c female mice.
    Mattos DM, Gomes ML, Freitas RS, Boasquevisque EM, Cardoso VN, Paula EF, Bernardo-Filho M.
    J Nucl Med Technol; 2000 Dec; 28(4):271-4. PubMed ID: 11142330
    [Abstract] [Full Text] [Related]

  • 32. Detection of cardiomyocyte death in a rat model of ischemia and reperfusion using 99mTc-labeled annexin V.
    Taki J, Higuchi T, Kawashima A, Tait JF, Kinuya S, Muramori A, Matsunari I, Nakajima K, Tonami N, Strauss HW.
    J Nucl Med; 2004 Sep; 45(9):1536-41. PubMed ID: 15347721
    [Abstract] [Full Text] [Related]

  • 33. Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors.
    Grimes J, Celler A, Birkenfeld B, Shcherbinin S, Listewnik MH, Piwowarska-Bilska H, Mikolajczak R, Zorga P.
    J Nucl Med; 2011 Sep; 52(9):1474-81. PubMed ID: 21795364
    [Abstract] [Full Text] [Related]

  • 34. Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters.
    Mozley PD, Stubbs JB, Plössl K, Dresel SH, Barraclough ED, Alavi A, Araujo LI, Kung HF.
    J Nucl Med; 1998 Dec; 39(12):2069-76. PubMed ID: 9867143
    [Abstract] [Full Text] [Related]

  • 35. Biodistribution and radiation dosimetry of [11C]raclopride in healthy volunteers.
    Ribeiro MJ, Ricard M, Bourgeois S, Lièvre MA, Bottlaender M, Gervais P, Dollé F, Syrota A.
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):952-8. PubMed ID: 15841376
    [Abstract] [Full Text] [Related]

  • 36. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies.
    Mejia AA, Nakamura T, Masatoshi I, Hatazawa J, Masaki M, Watanuki S.
    J Nucl Med; 1991 Apr; 32(4):699-706. PubMed ID: 2013810
    [Abstract] [Full Text] [Related]

  • 37. Effect of postconditioning on myocardial 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatment.
    Taki J, Higuchi T, Kawashima A, Fukuoka M, Kayano D, Tait JF, Matsunari I, Nakajima K, Kinuya S, Strauss HW.
    J Nucl Med; 2007 Aug; 48(8):1301-7. PubMed ID: 17631551
    [Abstract] [Full Text] [Related]

  • 38. Targeted imaging of gastrin-releasing peptide receptors with 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women.
    Santos-Cuevas CL, Ferro-Flores G, Arteaga de Murphy C, Pichardo-Romero PA.
    Nucl Med Commun; 2008 Aug; 29(8):741-7. PubMed ID: 18753829
    [Abstract] [Full Text] [Related]

  • 39. Biodistribution and dosimetry of iodine-123-IBF: a potent radioligand for imaging the D2 dopamine receptor.
    Mozley PD, Stubbs JB, Kung HF, Selikson MH, Stabin MG, Alavi A.
    J Nucl Med; 1993 Nov; 34(11):1910-7. PubMed ID: 8229233
    [Abstract] [Full Text] [Related]

  • 40. Fluorine-18-fluoro-L-DOPA dosimetry with carbidopa pretreatment.
    Brown WD, Oakes TR, DeJesus OT, Taylor MD, Roberts AD, Nickles RJ, Holden JE.
    J Nucl Med; 1998 Nov; 39(11):1884-91. PubMed ID: 9829576
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.